The effect of methylprednisolone treatment on cerebral reactivity in patients with multiple sclerosis

Author(s): Ozkan S, Uzuner N, Kutlu C, Ozbabalik D, Ozdemir G

Abstract

We assessed the effect of intravenous high-dose methylprednisolone (IVMP) on cerebral reactivity in multiple sclerosis (MS) patients during exacerbations by means of functional transcranial Doppler imaging. Forty-eight clinically defined MS patients were evaluated with visual evoked potentials (VEP) and functional transcranial Doppler sonography (TCD) of both posterior cerebral arteries before and after 5 days of 1000 mg IVMP. After treatment, mean Expanded Disability Status Scale score, mean blood flow velocities and mean blood flow velocities at rest and at stimulation, significantly decreased (p < 0.0001, for each). The change in cerebral blood flow velocity ratio (CBFv) with visual stimulation after treatment increased slightly (p = 0.20). All TCD parameters were not significantly correlated with VEP changes. In conclusion, we observed significant changes in CBFv with a non-significant increase in vascular reactivity after treatment with IVMP in exacerbations of MS. Case-control studies are necessary to draw conclusions regarding the beneficial effects of IVMP treatment.

Similar Articles

Neural network analysis of the P300 event-related potential in multiple sclerosis

Author(s): Slater JD, Wu FY, Honig LS, Ramsay RE, Morgan R

Event-related potentials in different subtypes of multiple sclerosis--a cross-sectional study

Author(s): Ellger T, Bethke F, Frese A, Luettmann RJ, Buchheister A, et al.

Cognition in epilepsy: a multichannel event related potential (P300) study

Author(s): Triantafyllou NI, Zalonis I, Kokotis P, Anthracopoulos M, Siafacas A, et al.

P300 event-related potentials in epileptic children

Author(s): Sunaga Y, Hikima A, Otsuka T, Nagashima K, Kuroume T

Auditory P300 event related potential in minor ischemic stroke

Author(s): Korpelainen JT, Kauhanen ML, Tolonen U, Brusin E, Mononen H, et al.

P300 assessment of early Alzheimer's disease

Author(s): Polich J, Ladish C, Bloom FE

Event-related auditory evoked potentials and multiple sclerosis

Author(s): Gil R, Zai L, Neau JP, Jonveaux T, Agbo C, et al.

Event-related potential P300 in multiple sclerosis

Author(s): Honig LS, Ramsay RE, Sheremata WA

Cognition in relapsing-remitting multiple sclerosis: a multichannel event-related potential (P300) study

Author(s): Triantafyllou NI, Voumvourakis K, Zalonis I, Sfagos K, Mantouvalos V, et al.

Transcranial Doppler and anesthetics

Author(s): Fodale V, Schifilliti D, Conti A, Lucanto T, Pino G, et al.

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

Author(s): Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, et al.

Cerebral blood flow and event-related potential in patients with multiple cerebral infarcts

Author(s): Tachibana H, Toda K, Yokota N, Sugita M, Konishi K

Influence of regional cerebral blood flow on event-related potential (P300)

Author(s): Kuwata T, Funahashi K, Maeshima S, Ogura M, Hyotani G, et al.

Cognitive dysfunction in congestive heart failure: transcranial Doppler evidence of microembolic etiology

Author(s): Jesus PA, Vieira-de-Melo RM, Reis FJ, Viana LC, Lacerda A, et al.

Cerebral perfusion in relation to cognitive function and type 2 diabetes

Author(s): Tiehuis AM, Vincken KL, van den Berg E, Hendrikse J, Manschot SM, et al.